World Diabetes Care Devices & Drugs Market to Post 5.2% CAGR to 2022, Expects Meticulous Research in Its Report Available at MarketPublishers.com03 Nov 2017 • by Natalie Aster
LONDON – Worldwide, the diabetes care devices & drugs market is poised gain momentum at a 5.2% CAGR in the offing to amount to USD 85,591.2 million by end-2022.
The market growth is primarily propelled by the rising prevalence and incidence rates of diabetes, technology advances, the rise of obesity, and increasing inactive lifestyles and poor diets. Although, high costs of diagnosis and treatment, dearth of awareness, and reimbursement issues are anticipated to somewhat restrain the growth of the sector.
Developments of novel formulations as well as technologies for insulin delivery are some of the major opportunity for this marketplace, whereas rigid regulations and registration procedure for the diabetes care devices & drugs present serious challenge to the growth of the diabetes care devices & drugs market space.
Diabetes care drugs market segment took the lead in the overall market in 2016, and is projected to increase to a great degree over the next 5-10 years. The market’s dominance is mainly due to the considerable demand for insulin and oral hypoglycemic agents to treat type I & II diabetes.
North America captured the lion’s share in the world diabetes care devices & drugs market as of 2016, with Europe and APAC following after.
In-demand study “Diabetes Care Devices & Drugs Market- Global Opportunity Analysis And Industry Forecast (2017-2022)” drawn up by Meticulous Market Research canvasses the market on a global level.
The report provides granular segmentation of the diabetes care devices and drugs marketplace based on type, and geography-wise; provides an evaluation of the high growth segments and regions.
It examines the historical evolution of the marketplace, current market development as well as provides future forecasts. The study limelights the market dynamics covering key challenges, drivers, opportunities, and trends in the world diabetes care devices & drugs market. The report offers an insightful discussion of the major world and regional players and analyses their shares of the market. It scrutinises the competitive scenario and discusses the market leaders by sub-region. The research limelights most recent developments in the market, discusses various strategies exploited by companies. The research report reviews the local emerging players in the world molecular cytogenetics market and shows how they compete with the market behemoths.
Visit Meticulous Research catalogue at MarketPublishers.com to find a full collection of the publisher’s reports.